Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Cornea Specialists (US)

Articles with lock require a subscription to GLG News | Request a free trial
July 14, 2008
Avastin is inexpensive for Macular Degeneration therapy
Analysis of: Costly Cancer Drug Offers Hope, but Also a Dilemma | www.nytimes.com
Author: GLG Expert Contributor
I and many other ophthalmologists around the country use Avastin intravitreally for wet macular degeneration in doses far smaller than those used for systemic cancer.  Although it is an "off-label" use of the drug, the cost for using Avastin is 1/6oth of Lucentis, a very similar...
June 5, 2008
This should be a significant advance.
Analysis of: Johnson & Johnson Vision Care Announces First Daily Disposable Silicone Hydrogel at BCLA | www.cltoday.com
Author: GLG Expert Contributor
This new lens represents a marriage of two important technologies in modern contact lens use; oxygen trasmissibility and convenience in wearing. This has the potential to become a significant portion of the contact lens market.
June 5, 2008
Implications for Astigmatism
Analysis of: Johnson & Johnson Vision Care Announces First Daily Disposable Silicone Hydrogel at BCLA | www.cltoday.com
Author: GLG Expert Contributor
Many patients who have irregular astigmatism will find a disposable silicone hydrogel lens to provide good vision with less irritation of the cornea due to protein build up in the lens.  This could be a big help to those who may not be LASIK candidates or who are awaiting future Custom LASIK surgery...
May 7, 2008
LASIK IS AN EXCELLENT PROCEDURE FOR THE APPROPRIATE CANDIDATES
Analysis of: LASIK Worries? Some May See Better with Alternatives | www.washingtonpost.com
Author: GLG Expert Contributor
The FDA report and scrutiny of LASIK complaints reveals what consientious LASIK surgeons have known for years:  Not everyone who walks through your doors is a good lasik candidate and you should not laser everyone.  About 1 out of 4 patients that consider lasik are actually good candidates...
April 7, 2008
The Next Big Thing in Cataract and Lens Based Surgery: The Light Adjustable Lens (LAL)
Analysis of: Pilot trial for toric correction with light-adjustable lens yields promising early results | ophthalmologytimes.modernmedicine.com
Author: GLG Expert Contributor
The light adjustable lens is a lens implant that is placed in the eye like a tradition intraocular lens during cataract surgery.  The unique difference is that it can be treated with a special light after surgical implant (weeks to months later) to correct any residual refractive errors or to fine...
Barry SchechterJanuary 29, 2008
Bausch makes foray into presbyopic arena
Analysis of: Bausch & Lomb announces acquisition of eyeonics | www.osnsupersite.com
Author: Barry Schechter, Director of Corneal and External Diseases, Florida Eye Microsurgical Institute, Inc.
With the recent trends of presbyopic correction , Bausch and Lomb has now entered the arena.
January 23, 2008
Benefits of TELESCOPIC lens implants important for those already effected by macular degeneration
Analysis of: Telescopic IOL device shows potential for improving quality of life in AMD patients | www.osnsupersite.com
Author: GLG Expert Contributor
As ophthalmologists, we have been waiting for development of a useful telescopic intraocular lens implant for over 17 years. These lenses have been in FDA trials for years, but never brought to market because of numerous problems with them. A viable telescopic lens implant would give us something to...
November 6, 2007
New Glaucoma Product Should Simplify Patient Compliance and Increase Allergan's Share of Glaucoma Market
Analysis of: Allergan, Inc. Receives FDA Approval For COMBIGAN™ (Brimonidine Tartrate/timolol Maleate Ophthalmic Solution) 0.2%/0.5% | www.medicalnewstoday.com
Author: GLG Expert Contributor
Patient compliance with glaucoma eyedrops is a key barrier in achieveing acceptable clinical outcomes. There is only one other product, Cosopt (by Merck) that offers a combination glaucoma medication. This medication may become a popular choice for glaucoma doctors to improve patient complian...
October 31, 2007
GENETECH BACKTRACKS ON ITS DECISION TO LIMIT AVASTIN FOR WET MACULAR DEGERNATION
Analysis of: Genentech revisits plan for Avastin | www.sfgate.com
Author: GLG Expert Contributor
In the two weeks since Genetech made its announcement that it would limit the availability of Avastin to ophthalmologists for use in treating wet macular degeneration the outcry from patients, ophthalmologists, politicians, and the American Academy of OPhthalmology has been so great that Genetech is...
October 29, 2007
American Academy of Ophthalmology Issues Press Statement Criticizing Genentech's Decision to Limit Avastin Availability for the Treatment of Wet Macular Degeneration
Analysis of: Ophthalmologists Concerned About AMD Patients’ Access To Avastin | aao.org
Author: GLG Expert Contributor
The American Academy of Ophthalmology said the recent decision by Genentech to limit availability of Avastin (bevacizumab) to compounding pharmacies could have a significant negative impact on the care of patients with age-related macular degeneration [AMD]. Dr. Charles Wilkinson, president of the AAO,...

Page : 1 2 3 4 5 6 Next1 to 10 of 58

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-01T09:45:16.773